Photos Reveal Moths Sipping Tears from a Moose

General-purpose humanoid robots and embodied AI continue to face significant challenges in real-world applications, primarily due to their inability to replicate the physical intuition that humans develop through experience. This limitation has resulted in a slow progression in the deployment of these technologies despite advancements in hardware.

The U.S. Food and Drug Administration (FDA) has approved a groundbreaking device designed to treat depression through brain stimulation at home, targeting a specific brain region known for regulating mood. This marks a significant advancement in mental health treatment options, potentially allowing patients to manage their symptoms more effectively in a familiar environment.